Bolt Biotherapeutics, Inc. (BOLT)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. William P. Quinn | CEO, CFO, President, Secretary & Director | 610.8k | -- | 1971 |
Dr. Edgar George Engleman M.D. | Founder & Member of Scientific Advisory Board | 40k | -- | 1946 |
Mr. Grant Yonehiro C.F.A., M.B.A. | Chief Operating Officer | 564.65k | -- | 1964 |
Dr. Randall C. Schatzman Ph.D. | Advisor | 872.7k | -- | 1955 |
Dr. Edith A. Perez M.D. | Advisor | 681.34k | -- | 1957 |
Ms. Sarah Nemec | VP of Finance & Principal Accounting Officer | -- | -- | 1976 |
Mr. Wesley Burwell | VP & Head of Human Resources | -- | -- | -- |
Dr. Nathan Ihle Ph.D. | Senior Vice President of Pharmaceutical Operations | -- | -- | -- |
Dr. Dawn Colburn BCOP, Pharm.D. | Senior Vice President of Clinical Development | -- | -- | -- |
Dr. Michael N. Alonso Ph.D. | Senior Vice President of Research | -- | -- | -- |
Bolt Biotherapeutics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 100
Description
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
Corporate Governance
Upcoming Events
August 5, 2024 at 10:59 AM UTC - August 9, 2024 at 12:00 PM UTC
Bolt Biotherapeutics, Inc. Earnings Date